Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PTPRF | P10586 | 6/20 | 0.32 |
| ▸ | PTPN2 | P17706 | 6/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.32 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.32 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23947861 | 0.96 | ALOX5 (0.35) | ALOX5KDM4EATML3MBTL1PTPRF | |
| SCHEMBL23947925 | 0.94 | PRKDC (0.35) | ALOX5KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL23947910 | 0.92 | ALOX5 (0.36) | ALOX5KDM4EATML3MBTL1PTPRF | |
| SCHEMBL24217010 | 0.92 | ALOX5 (0.37) | ALOX5PTPRFPTPN2PTPN1PRKDC | |
| SCHEMBL25927365 | 0.92 | ALOX5 (0.37) | ALOX5PTPRFPTPN2PTPN1PRKDC | |
| SCHEMBL25728601 | 0.92 | ALOX5 (0.37) | ALOX5PTPRFPTPN2PTPN1PRKDC | |
| SCHEMBL26725328 | 0.92 | ALOX5 (0.40) | ALOX5KDM4EATML3MBTL1PTPRF | |
| SCHEMBL21192031 | 0.92 | ALOX5 (0.41) | ALOX5KDM4EATML3MBTL1PTPRF | |
| SCHEMBL22258073 | 0.92 | ALOX5 (0.41) | ALOX5KDM4EATML3MBTL1PTPRF | |
| SCHEMBL25711408 | 0.91 | ALOX5 (0.35) | ALOX5PTPRFPTPN2PTPN1PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220123224-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-04-21 | — | — | US | disclosed |
| WO-2020045831-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME | 덕산네오룩스 주식회사 | 2020-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220123224-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, OR51E2, OR10J3 | ALOX5 849/4885KDM4E 636/4885ATM 4145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.